ICLR
Price
$168.70
Change
+$2.14 (+1.28%)
Updated
Apr 2, 04:59 PM (EDT)
Capitalization
27.35B
20 days until earnings call
IQV
Price
$174.37
Change
+$3.13 (+1.83%)
Updated
Apr 2 closing price
Capitalization
45.3B
27 days until earnings call
Ad is loading...

ICLR vs IQV

Header iconICLR vs IQV Comparison
Open Charts ICLR vs IQVBanner chart's image
ICON
Price$168.70
Change+$2.14 (+1.28%)
Volume$5.85K
Capitalization27.35B
IQVIA Holdings
Price$174.37
Change+$3.13 (+1.83%)
Volume$1.5M
Capitalization45.3B
ICLR vs IQV Comparison Chart
Loading...
ICLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ICLR vs. IQV commentary
Apr 03, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICLR is a Buy and IQV is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 03, 2025
Stock price -- (ICLR: $166.56 vs. IQV: $171.24)
Brand notoriety: ICLR: Not notable vs. IQV: Notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: ICLR: 131% vs. IQV: 80%
Market capitalization -- ICLR: $27.35B vs. IQV: $45.3B
ICLR [@Medical Specialties] is valued at $27.35B. IQV’s [@Medical Specialties] market capitalization is $45.3B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.27B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICLR’s FA Score shows that 0 FA rating(s) are green whileIQV’s FA Score has 0 green FA rating(s).

  • ICLR’s FA Score: 0 green, 5 red.
  • IQV’s FA Score: 0 green, 5 red.
According to our system of comparison, IQV is a better buy in the long-term than ICLR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICLR’s TA Score shows that 4 TA indicator(s) are bullish while IQV’s TA Score has 4 bullish TA indicator(s).

  • ICLR’s TA Score: 4 bullish, 3 bearish.
  • IQV’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ICLR is a better buy in the short-term than IQV.

Price Growth

ICLR (@Medical Specialties) experienced а -6.96% price change this week, while IQV (@Medical Specialties) price change was -5.60% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.75%. For the same industry, the average monthly price growth was +3.84%, and the average quarterly price growth was +3.01%.

Reported Earning Dates

ICLR is expected to report earnings on Apr 23, 2025.

IQV is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-1.75% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IQV($45.3B) has a higher market cap than ICLR($27.4B). ICLR has higher P/E ratio than IQV: ICLR (44.81) vs IQV (34.14). IQV YTD gains are higher at: -11.267 vs. ICLR (-19.556). IQV has higher annual earnings (EBITDA): 3.26B vs. ICLR (1.52B). IQV has more cash in the bank: 1.5B vs. ICLR (380M). ICLR has less debt than IQV: ICLR (3.94B) vs IQV (13.9B). IQV has higher revenues than ICLR: IQV (15B) vs ICLR (8.12B).
ICLRIQVICLR / IQV
Capitalization27.4B45.3B60%
EBITDA1.52B3.26B47%
Gain YTD-19.556-11.267174%
P/E Ratio44.8134.14131%
Revenue8.12B15B54%
Total Cash380M1.5B25%
Total Debt3.94B13.9B28%
FUNDAMENTALS RATINGS
ICLR vs IQV: Fundamental Ratings
ICLR
IQV
OUTLOOK RATING
1..100
5857
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
70
Overvalued
PROFIT vs RISK RATING
1..100
9369
SMR RATING
1..100
7541
PRICE GROWTH RATING
1..100
8563
P/E GROWTH RATING
1..100
9683
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICLR's Valuation (68) in the Pharmaceuticals Other industry is in the same range as IQV (70) in the Servicestothe Health Industry industry. This means that ICLR’s stock grew similarly to IQV’s over the last 12 months.

IQV's Profit vs Risk Rating (69) in the Servicestothe Health Industry industry is in the same range as ICLR (93) in the Pharmaceuticals Other industry. This means that IQV’s stock grew similarly to ICLR’s over the last 12 months.

IQV's SMR Rating (41) in the Servicestothe Health Industry industry is somewhat better than the same rating for ICLR (75) in the Pharmaceuticals Other industry. This means that IQV’s stock grew somewhat faster than ICLR’s over the last 12 months.

IQV's Price Growth Rating (63) in the Servicestothe Health Industry industry is in the same range as ICLR (85) in the Pharmaceuticals Other industry. This means that IQV’s stock grew similarly to ICLR’s over the last 12 months.

IQV's P/E Growth Rating (83) in the Servicestothe Health Industry industry is in the same range as ICLR (96) in the Pharmaceuticals Other industry. This means that IQV’s stock grew similarly to ICLR’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICLRIQV
RSI
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
70%
Bullish Trend 2 days ago
73%
Momentum
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
62%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
50%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 2 days ago
59%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
66%
Bearish Trend 2 days ago
63%
Advances
ODDS (%)
Bullish Trend 16 days ago
68%
Bullish Trend 10 days ago
62%
Declines
ODDS (%)
Bearish Trend 2 days ago
63%
Bearish Trend 2 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
75%
Bullish Trend 2 days ago
65%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
63%
View a ticker or compare two or three
Ad is loading...
ICLR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IQV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CMP9.310.19
+2.08%
Compass Minerals International
BFIN12.810.20
+1.63%
BankFinancial Corp
WMS109.991.01
+0.93%
Advanced Drainage Systems
NHI73.77-0.50
-0.67%
National Health Investors
HSDT0.41-0.03
-6.61%
Helius Medical Technologies

ICLR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICLR has been loosely correlated with IQV. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if ICLR jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICLR
1D Price
Change %
ICLR100%
+1.28%
IQV - ICLR
63%
Loosely correlated
+1.83%
RGEN - ICLR
62%
Loosely correlated
+1.88%
CRL - ICLR
44%
Loosely correlated
+2.25%
MEDP - ICLR
42%
Loosely correlated
+4.53%
TMO - ICLR
39%
Loosely correlated
+1.26%
More

IQV and

Correlation & Price change

A.I.dvisor indicates that over the last year, IQV has been closely correlated with CRL. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if IQV jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IQV
1D Price
Change %
IQV100%
+1.83%
CRL - IQV
70%
Closely correlated
+2.25%
ICLR - IQV
63%
Loosely correlated
+1.28%
MEDP - IQV
57%
Loosely correlated
+4.53%
TMO - IQV
56%
Loosely correlated
+1.26%
A - IQV
56%
Loosely correlated
+1.70%
More